The aesthetic injectables market in India is on a path to significant growth, with a projected compound annual growth rate (CAGR) of over 5 percent by 2030.

While the market currently represents just 1 percent of the Asia-Pacific (APAC) aesthetic injectables market by revenue in 2023, it is steadily gaining traction.

Aesthetic injectables like Botox, hyaluronic, and non-hyaluronic acid fillers are gaining popularity due to their non-surgical, non-invasive nature, successful outcomes, and minimal recovery time, making them an attractive choice for aesthetic enhancements.

The COVID-19 pandemic has played a role in this surge as it prompted people to become more mindful of their skin's needs and types. This awareness has led to a growing desire for elastic, rejuvenated, hydrated, and plump skin without the need for surgery. Many individuals are now willing to invest a portion of their disposable income in aesthetic enhancements, driving the market's growth.

The market's expansion has also led to a wider variety of injectable fillers available to surgeons. In addition, the use of virtual reality and artificial intelligence (AI) for precise skin-type recommendations and post-procedure monitoring is attracting a broader spectrum of customers, further fueling the market's development.

As beauty standards evolve, and technology and regulations advance, the aesthetic injectables market in India is set to flourish, offering a multitude of opportunities for both consumers and businesses. This growth trend underscores the rising significance of non-surgical aesthetic treatments in the region.